BOSTON (Reuters) - Newer “atypical” drugs for schizophrenia and other mental problems, which are supposed to be safer, may in fact carry a greater risk of a fatal heart attack than older medicines, researchers said on Wednesday.
BOSTON (Reuters) - Newer “atypical” drugs for schizophrenia and other mental problems, which are supposed to be safer, may in fact carry a greater risk of a fatal heart attack than older medicines, researchers said on Wednesday.
